1-4 of 4
Mark Goodman
Close
Sort by
Journal Articles

The Efficacy and Long-Term Toxicity of Intravenous Busulfan and Cyclophosphamide Conditioning Regimen for Stem Cell Transplantation in Advanced Lymphoma.

Edgardo S. Santos, M.D., Teresa DeCesare, M.D., Mark Goodman, M.D., Joseph D. Rosenblatt, M.D., Denise L. Pereira, M.D., Hugo F. Fernandez, M.D.
Journal: Blood
Blood (2004) 104 (11): 5215.
https://doi.org/10.1182/blood.V104.11.5215.5215
Published: 2004
Journal Articles

Safety and Efficacy of Large Volume Leukapheresis for Allogeneic Hematopoietic Progenitor Cell Transplantation- the University of Miami Experience.

Sherry Shariatmadar, MD, Mehdi Nassiri, MD, Mark Goodman, MD, Denise L. Pereira, MD, Hugo F. Fernandez, MD
Journal: Blood
Blood (2004) 104 (11): 5013.
https://doi.org/10.1182/blood.V104.11.5013.5013
Published: 2004
Journal Articles

Holmium-166 ( 166 Ho)-DOTMP Skeletal Targeted Radiotherapy (STR ™ ) with Melphalan and Autologous Peripheral Stem Cell Transplant (PBSCT) for Multiple Myeloma (MM).

Mark Goodman, M.D., William I. Bensinger, M.D., Sergio Giralt, M.D, Donna Salzman, M.D., Katherine L. Ruffner, M.D., Hazel B. Breitz, M.D.
Journal: Blood
Blood (2004) 104 (11): 922.
https://doi.org/10.1182/blood.V104.11.922.922
Published: 2004
Journal Articles

166 Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Clinical Trials & Observations
Sergio Giralt, William Bensinger, Mark Goodman, Donald Podoloff, Janet Eary, Richard Wendt, Raymond Alexanian, Donna Weber, David Maloney, Leona Holmberg, Joseph Rajandran, Hazel Breitz, Richard Ghalie, Richard Champlin
Journal: Blood
Blood (2003) 102 (7): 2684–2691.
https://doi.org/10.1182/blood-2002-10-3250
Published: 2003